Status:
COMPLETED
Methylphenidate for Treating Children With ADHD and Tourette Syndrome
Lead Sponsor:
Stony Brook University
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Attention Deficit Disorder With Hyperactivity
Tourette Syndrome
Eligibility:
All Genders
6-12 years
Phase:
NA
Brief Summary
This study will evaluate the safety and effectiveness of methylphenidate in treating attention deficit hyperactivity disorder in children with both attention deficit hyperactivity disorder and Tourett...
Detailed Description
Tourette syndrome is a neurological disorder that is characterized by repetitive, involuntary movements and vocalizations called tics. Many children with Tourette syndrome also have attention deficit ...
Eligibility Criteria
Inclusion
- Diagnosis of ADHD or ADHD plus Tourette syndrome
Exclusion
- Determined to be dangerous to self or others
- Scores less than 70 on an IQ test
- Any seizure disorder, major organic brain dysfunction, major medical illness, major mood disorder, psychosis, pervasive developmental disorder, or peripheral sensory loss
- Any condition that may make use of methylphenidate unsafe
Key Trial Info
Start Date :
February 1 2000
Trial Type :
INTERVENTIONAL
End Date :
January 1 2007
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT00441649
Start Date
February 1 2000
End Date
January 1 2007
Last Update
October 31 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.